Variable | Little/no | Moderate | Severe | Difference |
---|---|---|---|---|
Age (years) | 71.88 ± 9.02 | 70.87 ± 8.69 | 71.34 ± 8.76 | P > 0.05 |
Gender | ||||
Female | 18 (54.5%) | 69 (52.7%) | 28 (53.8%) | P > 0.05 |
Male | 15 (45.5%) | 62 (47.3%) | 24 (46.2%) | P > 0.05 |
Education | ||||
≦Primary | 22 (66.7%) | 88 (67.2%) | 35 (67.3%) | P > 0.05 |
≧Secondary | 11 (33.3%) | 43 (32.8%) | 17 (32.7%) | P > 0.05 |
Primary cancer site | ||||
Spine | 15 (26.3%) | 20 (27.8%) | 24 (27.6%) | P < 0.05 |
Other | 42 (73.7%) | 52 (72.2%) | 63 (72.4%) | P < 0.05 |
Chemotherapy and/or radiation for tumour | ||||
Chemotherapy and radiation | 10 (27.8%) | 15 (23.1%) | 28 (24.3%) | P < 0.05 |
Other | 26 (72.2%) | 50 (76.9%) | 87 (75.7%) | P < 0.05 |
Cognitive dysfunction | ||||
Depression | 12 (22.2%) | 20 (20.6%) | 10 (15.4%) | P < 0.05 |
Disruptive behaviour | 2 (7.4%) | 4 (9.3%) | 3 (10.8%) | P < 0.05 |
Functional status (activities of daily living) | ||||
Fully dependent | 9 (20.9%) | 15 (21.1%) | 28 (27.5%) | P < 0.05 |
Other | 20 (46.5%) | 30 (42.3%) | 49 (48.0%) | P < 0.05 |
Tumour site | ||||
Thoracic | 16 (48.5%) | 64 (48.8%) | 25 (48.1%) | P > 0.05 |
Other | 17 (51.5%) | 67 (51.2%) | 27 (51.9%) | P > 0.05 |
Paralysis | ||||
Yes | 12 (36.4%) | 45 (34.4%) | 18 (34.6%) | P < 0.05 |
Pain, VAS score | ||||
< 3 | 7 (21.2%) | 28 (21.4%) | 11 (21.2%) | P < 0.05 |
≧4 | 26 (78.8%) | 103 (78.6%) | 41 (78.8%) | P < 0.05 |